Evidence map›Paper›PMID 41580395›Full record

ArticleNature communications2026

Atroposelective interrupted CuAAC reaction using cyclic diaryliodoniums.

Yuanyuan Li, Shan Yang, Longhui Duan, Zhenhua Gu

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuanyuan LiDepartment of Chemistry, University of Science and Technology of China, Hefei, Anhui, PR China.
Shan YangDepartment of Chemistry, University of Science and Technology of China, Hefei, Anhui, PR China.
Longhui DuanDepartment of Chemistry, University of Science and Technology of China, Hefei, Anhui, PR China.
Zhenhua GuDepartment of Chemistry, University of Science and Technology of China, Hefei, Anhui, PR China. zhgu@ustc.edu.cn.ORCID http://orcid.org/0000-0001-8168-2012

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22301291
6 · The paper itself

Abstract

Copper-catalyzed azide-alkyne cycloaddition (CuAAC) is a pivotal strategy for joining two fragments, including bioactive moieties under mild conditions. In recent years, "interrupted" CuAAC reaction has emerged by intercepting copper triazolide intermediates, thereby significantly broadening the scope of these transformations. However, asymmetric transformations based on the interruption of copper triazolide intermediates have remained elusive. In this work, we present an efficient and mild approach that intercepts a copper triazolide intermediate with a cyclic diaryliodonium reagent, enabling a three-component coupling of the cyclic diaryliodonium species, an alkyne, and an azide under atroposelective control. This method constitutes an asymmetric interrupted CuAAC reaction and furnishes a diverse array of structurally unique atropisomeric biaryl triazoles. Mechanistic investigations reveal an unusual secondary kinetic isotope effect for the terminal alkyne, while in situ calorimetry-based reaction progress kinetic analysis identifies the individual reaction orders of each substrate: formal 0.4th-order for cyclic diaryliodonium and first-order for both the alkyne and the azide. The overall rate is governed by copper-mediated cyclometallation of the alkyne and azide, as well as the oxidative addition of the copper triazolide intermediate to the cyclic diaryliodonium reagent.

Identifiers

PMID41580395
PMCPMC12831795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.